Common plasma protein marker LCAT in aggressive human breast cancer and canine mammary tumor
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Breast cancer is one of the most frequently diagnosed cancers. Although biomarkers are continuously being discovered, few specific markers, rather than classification markers, representing the aggressiveness and invasiveness of breast cancer are known. In this study, we used samples from canine mammary tumors in a comparative approach. We subjected 36 fractions of both canine normal and mammary tumor plasmas to highperformance quantitative proteomics analysis. Among the identified proteins, LCAT was selectively expressed in mixed tumor samples. With further MRM and Western blot validation, we discovered that the LCAT protein is an indicator of aggressive mammary tumors, an advanced stage of cancer, possibly highly metastatic. Interestingly, we also found that LCAT is overexpressed in high-grade and lymph-node-positive breast cancer in silico data. We also demonstrated that LCAT is highly expressed in the sera of advanced-stage human breast cancers within the same classification. In conclusion, we identified a possible common plasma protein biomarker, LCAT, that is highly expressed in aggressive human breast cancer and canine mammary tumor.
Abstract
Breast cancer is one of the most frequently diagnosed cancers. Although biomarkers are continuously being discovered, few specific markers, rather than classification markers, representing the aggressiveness and invasiveness of breast cancer are known. In this study, we used samples from canine mammary tumors in a comparative approach. We subjected 36 fractions of both canine normal and mammary tumor plasmas to highperformance quantitative proteomics analysis. Among the identified proteins, LCAT was selectively expressed in mixed tumor samples. With further MRM and Western blot validation, we discovered that the LCAT protein is an indicator of aggressive mammary tumors, an advanced stage of cancer, possibly highly metastatic. Interestingly, we also found that LCAT is overexpressed in high-grade and lymph-node-positive breast cancer in silico data. We also demonstrated that LCAT is highly expressed in the sera of advanced-stage human breast cancers within the same classification. In conclusion, we identified a possible common plasma protein biomarker, LCAT, that is highly expressed in aggressive human breast cancer and canine mammary tumor.
참고문헌 (27)
- Woolston C, "Breast cancer", Nature, 527, pp.S101~ (2015)
- Hoag H, "Molecular biology : marked progress", Nature, 527, pp.S114~S115 (2015)
- Ulaner GA, "Molecular imaging of biomarkers in breast cancer", J Nucl Med, 57(Suppl 1), pp.53S~59S (2016)
- Harris L, "American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer", J Clin Oncol, 25, pp.5287~5312 (2007)
- Geyer PE, "Revisiting biomarker discovery by plasma proteomics", Mol Syst Biol, 13, pp.942~ (2017)
- Banin Hirata BK, "Molecular markers for breast cancer : prediction on tumor behavior", Dis Markers, 2014, pp.513158~ (2014)
- Salas Y, "Epidemiological study of mammary tumors in female dogs diagnosed during the period 2002-2012 : a growing animal health problem", PLoS One, 10, pp.e0127381~ (2015)
- Dantas Cassali G, "Canine mammary mixed tumours : a review", Vet Med Int, 2012, pp.274608~ (2012)
- de Ronde JJ, "SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancer", Breast Cancer Res Treat, 137, pp.213~223 (2013)
- Xie X, "Identification of differentially expressed proteins in the injured lung from zinc chloride smoke inhalation based on proteomics analysis", Respir Res, 20, pp.36~ (2019)
- Dobiasova M, "Advances in understanding of the role of lecithin cholesterol acyltransferase(LCAT)in cholesterol transport", Clin Chim Acta, 286, pp.257~271 (1999)
- Subbaiah PV, "Impaired cholesterol esterification in the plasma in patients with breast cancer", Lipids, 32, pp.157~162 (1997)
- Rakha EA, "Impact of breast cancer grade discordance on prediction of outcome", Histopathology, 73, pp.904~915 (2018)
- Rahman M, "Breast cancer metastasis and the lymphatic system", Oncol Lett, 10, pp.1233~1239 (2015)
- Lindblad-Toh K, "Genome sequence, comparative analysis and haplotype structure of the domestic dog", Nature, 438, pp.803~819 (2005)
- Abdelmegeed SM, "Canine mammary tumors as a model for human disease", Oncol Lett, 15, pp.8195~8205 (2018)
- Lee KH, "Transcriptome signatures of canine mammary gland tumors and its comparison to human breast cancers", Cancers (Basel), 10, pp.317~ (2018)
- Tavasoly A, "Classification and grading of canine malignant mammary tumors", Vet Res Forum, 4, pp.25~30 (2013)
- Surinova S, "On the development of plasma protein biomarkers", J Proteome Res, 10, pp.5~16 (2011)
- Kosek AB, "Binding affinity and reactivity of lecithin cholesterol acyltransferase with native lipoproteins", Biochem Biophys Res Commun, 258, pp.548~551 (1999)
- Cedo L, "HDL and LDL : potential new players in breast cancer development", J Clin Med, 8, pp.853~ (2019)
- Hilal Kiziltunç Özmen, "Lecithin: Cholesterol Acyltransferase and Na+-K+-ATPase Activity in Patients with Breast Cancer", Journal of Breast Cancer, 16(2), pp.159~163 (2013), 한국유방암학회
- Beeghly-Fadiel A, "A Mendelian randomization analysis of circulating lipid traits and breast cancer risk", Int J Epidemiol, 49, pp.1117~1131 (2019)
- Jiang JT, "Metabolism of high density lipoproteins in liver cancer", World J Gastroenterol, 13, pp.3159~3163 (2007)
- Wisniewski JR, "Universal sample preparation method for proteome analysis", Nat Methods, 6, pp.359~362 (2009)
- Kim YI, "Meta-markers for the differential diagnosis of lung cancer and lung disease", J Proteomics, 148, pp.36~43 (2016)
- Cho HM, "Targeted genome engineering to control VEGF expression in human umbilical cord blood-derived mesenchymal stem cells : potential implications for the treatment of myocardial infarction", Stem Cells Transl Med, 6, pp.1040~1051 (2017)